Hutch News

Two lifetimes’ worth of bone marrow transplant breakthroughs

Two lifetimes’ worth of bone marrow transplant breakthroughs

Bone marrow transplant pioneer Dr. Rainer Storb retires and reflects on six decades of science and mentorship
Hutch NewsAugust 14, 2025
Effective immunotherapy for relapsed or treatment-resistant leukemia

Effective immunotherapy for relapsed or treatment-resistant leukemia

From Dr. Jordan Gauthier and colleagues, Clinical Research Division
Science SpotlightNovember 20, 2023
Dr. Mazyar Shadman receives the 2021 Ali Al-Johani Award

Dr. Mazyar Shadman receives the 2021 Ali Al-Johani Award

Oncologist lauded for his compassion and care for bone marrow transplant patients
Hutch NewsMarch 31, 2021
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions

If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions

From the Turtle group and collaborators, Clinical Research Division
Science SpotlightNovember 16, 2020
Gaining gastrointestinal GVHD control

Gaining gastrointestinal GVHD control

Phase III clinical trial on drug therapy to combat graft-vs.-host disease in stem-cell patients shows significant reduction in deaths
Hutch NewsJanuary 29, 2007
For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse

For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse

The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients
News ReleasesOctober 08, 2003